Neurocrine Biosciences, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $3.0M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $33.7M |
| SG&A Expense | $14.4M |
| Operating Income | $-53.7M |
| Operating Margin | -1,817.5% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-51.0M |
| Net Margin | -1,728.3% |
| EPS (Basic) | $-1.30 |
| EPS (Diluted) | $-1.30 |
| Shares Outstanding (Basic) | 39.1M |
| Shares Outstanding (Diluted) | 39.1M |
| Dividends Per Share | — |